Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
PISKEL KYLE
Chief Financial Officer at Adaptive Biotechnologies. Filing since 7 Mar 2022.
CIK 0001780662
Company
Date
Role
Action
Shares
Amount
Of holding
ADPT
Adaptive Biotechnologies Corp
18 May 2026
Chief Financial Officer
Sold at will
3,115
$40.62K
1.2%
ADPT
Adaptive Biotechnologies Corp
11 Mar 2026
Chief Financial Officer
Sold at will
18,672
$245.91K
6.7%
ADPT
Adaptive Biotechnologies Corp
4 Feb 2026
Chief Financial Officer
Sold on a plan
2,145
$39.60K
1.0%
ADPT
Adaptive Biotechnologies Corp
12 Jan 2026
Chief Financial Officer
Sold on a plan
4,290
$77.22K
1.9%
ADPT
Adaptive Biotechnologies Corp
28 Nov 2025
Chief Financial Officer
Sold on a plan
162,820
$3.17M
42.9%
ADPT
Adaptive Biotechnologies Corp
17 Nov 2025
Chief Financial Officer
Sold at will
238
$3.34K
0.1%
ADPT
Adaptive Biotechnologies Corp
16 May 2025
Chief Financial Officer
Sold at will
1,929
$17.15K
0.7%
ADPT
Adaptive Biotechnologies Corp
5 Mar 2025
Chief Financial Officer
Sold at will
10,320
$72.07K
3.7%
ADPT
Adaptive Biotechnologies Corp
18 Nov 2024
Chief Financial Officer
Sold at will
248
$1.24K
0.2%
ADPT
Adaptive Biotechnologies Corp
5 Mar 2024
Principal Accounting Officer
Sold at will
7,727
$26.50K
5.9%
ADPT
Adaptive Biotechnologies Corp
16 Nov 2023
Principal Accounting Officer
Sold at will
259
$1.07K
0.3%
ADPT
Adaptive Biotechnologies Corp
6 Mar 2023
Principal Accounting Officer
Sold, plan not stated
3,529
$30.25K
3.9%
ADPT
Adaptive Biotechnologies Corp
16 Nov 2022
Principal Accounting Officer
Sold, plan not stated
959
$8.51K
2.0%
ADPT
Adaptive Biotechnologies Corp
7 Mar 2022
Principal Accounting Officer
Sold, plan not stated
220
$2.64K
0.5%
14 decisions on file.
